Andrea Streit, Magdalena Hoffmann, Andreas Blesl, Christine Maria Schwarz, Andrea Borenich, Gerhard Pretterhofer, Gernot Brunner
{"title":"The Blaylock Risk Assessment Screening Score in Neurology-A Monocentric Cohort Study.","authors":"Andrea Streit, Magdalena Hoffmann, Andreas Blesl, Christine Maria Schwarz, Andrea Borenich, Gerhard Pretterhofer, Gernot Brunner","doi":"10.1097/QMH.0000000000000543","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Effective discharge planning is an important factor of hospital care and should follow a comprehensive assessment of patients at risk for adverse events during discharge. The study's aim was to analyze whether the use of the Blaylock Risk Assessment Screening Score (BRASS) at admission leads to a reduction in the hospital length of stay (LOS), a reduction in readmission rates, an influence on the discharge destination at the University Hospital of Graz, and an increase of the end user's satisfaction.</p><p><strong>Methods: </strong>BRASS was implemented into the routine nursing assessment at admission for 3 months in 2021 at 2 Neurology wards at the University Hospital of Graz. These data were retrospectively compared to 2 previous time periods without BRASS. For the prospective part of this study, a paper-based survey was performed to analyze the satisfaction of the nurses at the 2 wards with the application of BRASS.</p><p><strong>Results: </strong>The median LOS was significantly longer during the time of the assessment with BRASS as compared to the 2 years before [8 (4, 14) days in 2021, 6 (4, 10) days in 2020, 6 (4, 9) days in 2019; 2021 vs 2020: P = .002; 2021 vs 2019: P < .001]. Readmission rates did not differ significantly, but outpatient readmission decreased compared to 2019 (17% in 2021, 23% in 2019, P = .040).</p><p><strong>Conclusion: </strong>The use of BRASS did not reduce the length of hospital stay compared to the 2 years before, but outpatient readmission rates decreased and discharge home was more frequent. Therefore, BRASS might be a helpful tool to improve discharge management and avoid readmissions.</p>","PeriodicalId":20986,"journal":{"name":"Quality Management in Health Care","volume":" ","pages":"153-159"},"PeriodicalIF":1.4000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Quality Management in Health Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QMH.0000000000000543","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/21 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives: Effective discharge planning is an important factor of hospital care and should follow a comprehensive assessment of patients at risk for adverse events during discharge. The study's aim was to analyze whether the use of the Blaylock Risk Assessment Screening Score (BRASS) at admission leads to a reduction in the hospital length of stay (LOS), a reduction in readmission rates, an influence on the discharge destination at the University Hospital of Graz, and an increase of the end user's satisfaction.
Methods: BRASS was implemented into the routine nursing assessment at admission for 3 months in 2021 at 2 Neurology wards at the University Hospital of Graz. These data were retrospectively compared to 2 previous time periods without BRASS. For the prospective part of this study, a paper-based survey was performed to analyze the satisfaction of the nurses at the 2 wards with the application of BRASS.
Results: The median LOS was significantly longer during the time of the assessment with BRASS as compared to the 2 years before [8 (4, 14) days in 2021, 6 (4, 10) days in 2020, 6 (4, 9) days in 2019; 2021 vs 2020: P = .002; 2021 vs 2019: P < .001]. Readmission rates did not differ significantly, but outpatient readmission decreased compared to 2019 (17% in 2021, 23% in 2019, P = .040).
Conclusion: The use of BRASS did not reduce the length of hospital stay compared to the 2 years before, but outpatient readmission rates decreased and discharge home was more frequent. Therefore, BRASS might be a helpful tool to improve discharge management and avoid readmissions.
期刊介绍:
Quality Management in Health Care (QMHC) is a peer-reviewed journal that provides a forum for our readers to explore the theoretical, technical, and strategic elements of health care quality management. The journal''s primary focus is on organizational structure and processes as these affect the quality of care and patient outcomes. In particular, it:
-Builds knowledge about the application of statistical tools, control charts, benchmarking, and other devices used in the ongoing monitoring and evaluation of care and of patient outcomes;
-Encourages research in and evaluation of the results of various organizational strategies designed to bring about quantifiable improvements in patient outcomes;
-Fosters the application of quality management science to patient care processes and clinical decision-making;
-Fosters cooperation and communication among health care providers, payers and regulators in their efforts to improve the quality of patient outcomes;
-Explores links among the various clinical, technical, administrative, and managerial disciplines involved in patient care, as well as the role and responsibilities of organizational governance in ongoing quality management.